Georgia Cancer Specialists

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 42 papers

  • Open Access
  • Research Article

P-550. Efficacy and Safety of B/F/TAF in Black Adults with HIV Who Are Treatment Naïve: 5-Year Follow-Up from Two Phase 3 Studies

  • Jan 29, 2025
  • Open Forum Infectious Diseases
  • Anson K Wurapa +8
  • Research Article
  • Citations35

Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy

  • Nov 11, 2023
  • Blood
  • Jonathan W Friedberg +10
  • Open Access
  • Abstract
  • Citations3

1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two Phase 3 randomized clinical trials

  • Dec 15, 2022
  • Open Forum Infectious Diseases
  • Moti Ramgopal +14
  • Research Article
  • Citations12

Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection.

  • Sep 19, 2021
  • Annals of Surgical Oncology
  • Robert J Torphy +12
  • Research Article
  • Citations26

One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses.

  • May 01, 2021
  • ImmunoHorizons
  • Natalie S Haddad +37
  • Open Access
  • Research Article
  • Citations10

Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA)

  • Nov 19, 2020
  • Journal of immunological methods
  • Natalie S Haddad +13
  • Open Access
  • Research Article
  • Citations46

Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.

  • Jun 23, 2020
  • American journal of medical genetics. Part A
  • Johanna L Schmidt +26
  • Open Access
  • Abstract
  • Citations5

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease on Chronic Hemodialysis

  • Oct 23, 2019
  • Open Forum Infectious Diseases
  • Joseph J Eron +16
  • Open Access
  • Research Article

P1.16-48 Experiences of Pts on 1st Line Care (EP1C): Symptoms and Impacts of EGFR TKI Therapy on Real-World Daily Lives of NSCLC Pts

  • Oct 01, 2019
  • Journal of Thoracic Oncology
  • I Elkins +7
  • Open Access
  • Research Article
  • Citations1

Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study

  • Jul 01, 2019
  • Annals of Oncology
  • M Saleh +12
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.